A liquid crystal-based sensor platform for rapid, naked-eye detection of acrylamide in water. The technology uses a thiol-ene click reaction at the LC-water interface to trigger a visible optical change, enabling sensitive and selective detection within minutes without specialized instrumentation.
This technology offers a rapid, naked-eye detection method for acrylamide in water using thermotropic liquid crystal (LC) films. Acrylamide is a known contaminant of concern in drinking water and certain food products, and current analytical methods typically require laboratory instrumentation and lengthy processing. The proposed LC-based sensor is designed to deliver a visible optical response within minutes when acrylamide is present, making it suitable for field screening, environmental monitoring, and food safety applications where quick decision-making is critical.
The core value proposition is a low-cost, instrument-free detection platform that combines selectivity for acrylamide with a clear, visually interpretable output. By leveraging the sensitivity of LC ordering transitions to interfacial chemistry, the sensor can translate a molecular recognition event into a change in optical appearance that can be observed directly or captured with a simple camera.
The underlying thiol-ene reaction between acrylamide and octadecanethiol has been demonstrated under UV light over 5 to 10 minutes. The team is now working to integrate this chemistry into the LC film sensing format and validate that the resulting interfacial change produces a visible optical response in the LC film. Planned experiments will use polarized light microscopy and naked-eye visualization to study the effect of photoinitiator, thiol, and acrylamide concentrations on sensor sensitivity and response rate, and to develop a companion app for automated inspection. The technology is at an early-to-mid stage of laboratory validation toward a practical acrylamide detection platform.
The Ohio State University is a comprehensive public land‑grant research university in Columbus, serving one of the nation’s largest student populations and a broad research enterprise. Industry partners engage through an integrated academic medical center for clinical translation, a campus‑adjacent innovation district for co‑located projects, and a statewide extension network that pilots solutions across Ohio. Corporate engagement provides a single front door for sponsored research, talent pipelines, and streamlined agreements. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, USDA, DoD, and NASA. A dedicated technology transfer office and venture support help protect IP, license technologies, and launch startups.